Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies.

Abramowicz D, Norman DJ, Goldman M, De Pauw L, Kinnaert P, Kahana L, Thistlethwaite JR, Shield CF, Monaco AP, Vanherweghem JL, et al. OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies. Transplant Proc. 1995 Feb; 27(1):852-3.

View in: PubMed

collapse authors with profiles